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Abstract
NOD2 receptor and the cytosolic protein kinase RIPK2 regulate NF-κB and MAP kinase signaling
during bacterial infections, but the role of this immune axis during viral infections has not been
addressed. We demonstrate that Nod2−/− and Ripk2−/− mice are hypersusceptible to influenza A
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virus infection. Ripk2−/− cells displayed defective mitophagy leading to enhanced mitochondrial
superoxide production and accumulation of damaged mitochondria resulting in increased NLRP3
inflammasome activation and IL-18 production. RIPK2 regulated mitophagy in a kinase-
dependent manner by phosphorylating the mitophagy inducer ULK1. Accordingly, Ulk1−/− cells
displayed enhanced mitochondrial superoxide production and caspase-1 activation. These results
demonstrate a role for NOD2-RIPK2 signaling in protection against virally triggered
immunopathology by negatively regulating NLRP3 inflammasome activation and IL-18
production via ULK1-dependent mitophagy.
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Seasonal influenza A virus (IAV) epidemics are a major cause of morbidity and economic
loss, with annual mortality rates estimated in the 9,000–45,000 range for the USA alone1. In
addition, global pandemics of antigenically-novel IAV strains that emerge from avian and
domestic swine reservoirs can result in the death of millions. The catastrophic 1918 H1N1
pandemic was characterized by an unusually high incidence of rapid lethality in otherwise
healthy young adults2. More recently, similar pathological profiles have been documented
for infections caused by the highly virulent avian H5N1 IAV strains3, 4. In both humans and
animal models, infections with these highly-pathogenic strains were characterized by rapid
onset of a pro-inflammatory `cytokine storm' that caused damage to the lung epithelium,
edema, and hemorrhage. Relative to the host responses induced by low-pathogenicity
influenza viruses, infections with the 1918 H1N1 or highly-pathogenic H5N1 viruses are
associated with markedly increased neutrophil and macrophage infiltration and elevated
cytokines and chemokines, including IL-1β, IFN-γ and TNF4–6. Thus, in addition to virus
replication, it has become increasingly clear that the severity of the inflammatory response
to IAV infection contributes significantly to morbidity and mortality.
The signaling pathways regulating the innate immune response to IAV infection are now
being defined, with obvious roles for the endocytic Toll-like receptors TLR37 and TLR78,
and the cytosolic receptor RIG-I9. Recently, members of the Nod-like receptor (NLR)
family have also been shown to recognize IAV in the cytosolic compartment10–12. NLRP3
detects IAV infection through multiple mechanisms, including ion flux generated by the
virus encoded M2 ion channel11 and via the recognition of viral RNA10, 13. These signals
serve to activate the inflammasome, a macromolecular complex consisting of caspase-1, the
adaptor protein ASC and NLRP314. Inflammasome activation leads to the cleavage of
numerous substrates, including pro-IL-1β and pro-IL-18, and the initiation of the pro-
inflammatory form of cell death known as pyroptosis15.
Autophagy is a cellular process where cytoplasmic double membrane vesicles are formed
and engulf cytoplasmic contents. Several forms of autophagy exist, including
macroautophagy, where long-lived proteins or organelles are engulfed and degraded for
recycling16. It should be noted that macroautophagy was recently shown to be a critical
modulator of inflammasome activation17, but it is unknown if this is applicable during viral
infection. Another subset of the autophagic process is known as mitophagy, wherein
mitochondria are specifically degraded in response to damage or developmental cues18, 19.
Finally, xenophagy is an innate immune mechanism where invading cytosolic pathogens are
captured and degraded to prevent their further spread and for antigen presentation to initiate
adaptive immunity20, 21.
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Receptor interacting protein kinase 2 (RIPK2 also known as RIP2 or RICK) is a critical
mediator of inflammatory responses to bacterial infections, where it is activated by the
NLRs NOD1 and NOD2. RIPK2 is involved in the induction of xenophagy in response to
bacterial infections20, 22, 23. Furthermore, the sensing of bacterial peptidoglycan components
activates the NOD1-NOD2-RIPK2 axis and signals through NF-κB and MAP kinase
(MAPK) to activate inflammatory cells and to promote secretion of proinflammatory
cytokines and chemokines24. Although NOD2 regulates type I interferon production during
viral infections independently of RIPK225, 26, the putative roles of RIPK2 during IAV
infection have not been determined. Here, we demonstrate that Ripk2−/− mice are
hypersusceptible to IAV infection. RIPK2 dampens inflammasome activation and IL-18
secretion, which contribute critically to disease progression. Mechanistically, increases in
IL-18 production and inflammasome activation are a consequence of defective mitophagy
induction in IAV-infected Ripk2−/− mice and immune cells. Finally we demonstrate that
activation of the critical autophagy inducer ULK1 is reduced in Ripk2−/− cells and that
Ulk1−/− cells also display increased inflammasome activation and reduced mitophagy. Our
results highlight a previously unknown RIPK2-dependent signaling network that negatively
regulates inflammasome activation through mitophagy during viral infection.
Results
RIPK2 protects against severe IAV infection
To examine the potential role of NOD2 and RIPK2 in the immune response to IAV
infection, wildtype (WT), Nod2−/− and Ripk2−/− mice were challenged intranasally (i.n.)
with the virulent influenza A/PR/8/34 (PR8) H1N1 virus and survival was monitored over
time. Relative to wildtype (WT) controls, Nod2−/− and Ripk2−/− mice were significantly
more susceptible (Fig. 1a). While signs of pathological damage to the lungs of WT mice
were minimal by day (d) 2 after PR8 inoculation, lung sections of both knockout mouse
lines showed marked pathological changes characterized by greater pulmonary airway
obstruction and increased cell death on d2 and d7 after infection (Fig. 1b–d and data not
shown). Moreover, airway obstruction of IAV-infected Ripk2−/− mice consisted mainly of
neutrophils (Fig. 1e). While neutrophil counts were elevated in the Ripk2−/− whole lung on
d2 and d7, no increases were observed in the numbers of other myeloid cells (Fig. 1f–g).
Despite the increased susceptibility of Ripk2−/− mice to IAV infection, lung virus titers were
comparable to those in the WT controls (Fig. 1h). Thus, NOD2 and RIPK2 protects against
severe IAV infection, although this is not correlated with the extent of virus replication.
RIPK2 regulates IFN-γ and IL-18
Given that the inflammatory response to IAV is thought to contribute to mortality3, 4, we
investigated the role of RIPK2 in cytokine production. To this end, whole lung homogenates
were taken on days 2 and 7 after i.n. challenge of WT and Ripk2−/− mice with the PR8 virus,
and the extent of inflammatory mediator production was determined by ELISA. Although
RIPK2 regulates IL-6 and TNF production during bacterial infections27, no significant
differences in the levels of these cytokines were observed in lungs of virus-infected WT and
Ripk2−/− mice (Fig. 2a). In contrast, IFN-γ, a known mediator of inflammation in viral
immunity28, and IL-18 were significantly upregulated in Ripk2−/− mice (Fig. 2b). IL-18 was
originally identified as an IFN-γ-inducing cytokine29, suggesting that IFN-γ production
might be consequential to increased IL-18 release in IAV-infected Ripk2−/− mice. Previous
studies have shown the chemokines CCL2 (MCP-1) and CXCL10 (IP-10) were induced by
IL-18 and IFN-γ30 and accordingly, we observed elevated production of both CCL2 and
CXCL10 in IAV-infected Ripk2−/− mice (Fig. 2c). These results indicate that increased
susceptibility to IAV infection in Ripk2−/− mice is associated with exacerbated production
of IL-18 and IFN-γ.
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IL-18 antagonism in Ripk2−/− mice improves survival
We hypothesized that increased IL-18 production was responsible for the elevated IAV
susceptibility of Ripk2−/− mice. To test this, Ripk2−/− mice were injected intraperitoneally
(i.p.) with anti-IL-18 neutralizing antibody 3h prior to PR8 infection. This treatment
significantly reduced IL-18 and IFN-γ levels in the lungs of IAV-infected Ripk2−/− mice
(Fig. 3a). This was followed by significantly reduced CCL2 levels, while the concentration
of the chemokines CXCL10, CXCL1 (KC) and CCL3 (MIP-1α) protein- albeit not
statistically significant - showed a trend towards diminished expression (Supplementary Fig.
1a). Furthermore, IL-18 neutralization dampened virus-induced lung pathology and airway
neutrophilia (Fig. 3b–c and Supplementary Fig. 1b), and significantly improved survival
(Fig. 3d). These results suggest that increased IL-18 production drives elevated morbidity
and mortality in IAV-infected Ripk2−/− mice. To further confirm the critical role of IL-18 in
this process, we generated mice lacking both RIPK2 and IL-18 (Ripk2−/−Il18−/− mice) and
challenged these animals with a lethal dose of IAV. As with Ripk2−/− mice receiving IL-18-
neutralizing antibodies, genetic ablation of IL-18 rescued the hypersensitive response of
Ripk2−/− mice; tissue neutrophil infiltration and mortality rates returned to levels
comparable to those of infected WT mice (Fig. 3e–f). Overall, these results demonstrate a
critical role for elevated IL-18 production increasing morbidity and mortality in IAV-
infected Ripk2−/− mice.
Immune and lung cells contribute to elevated IL-18
We next set out to identify the cellular compartments that contribute to RIPK2-mediated
modulation of IL-18. Bone marrow (BM) chimeras were generated that selectively
expressed RIPK2 in the radiation-sensitive (donor BM) or radiation-resistant (recipient lung)
compartments. These chimeric mice were subsequently infected i.n. with PR8, and IL-18
production was assessed by immunohistochemistry (IHC) and ELISA. Both Ripk2−/−
hematopoietic and non-immune (likely lung epithelial) cells contributed to increased
production of IL-18 in the pulmonary tract of IAV-infected Ripk2−/− mice (Fig. 4a–b, and
Supplementary Fig. 2a).
Innate and adaptive lymphocytes are hyperactivated
We next examined the cellular populations that were responsible for the increased IFN-γ
observed in Ripk2−/− mice. Both NK cells and CD8+ T cells isolated from PR8-infected
Ripk2−/− mice produced larger quantities of IFN-γ on a per-cell basis and were more highly
activated, although the absolute numbers of these cells remained similar to those in WT
mice (Fig. 4c–f, and Supplementary Fig. 2b–d). These results indicate that increased IL-18
in Ripk2−/− mice subsequently leads to increased IFN-γ production from innate and adaptive
cell populations.
NOD2-RIPK2 axis regulates caspase-1 activation and IL-18
NOD2 was reported to regulate type I IFN during IAV infection25, 26. We therefore
examined type I IFN levels in IAV-infected Ripk2−/− mice. Although we confirmed the
reported defect in type I IFN production in Nod2−/− alveolar macrophages, Ripk2−/−
macrophages produced type I IFN (IFN-β) protein in amounts similar to those of WT cells
(data not shown), suggesting that differences in type I IFN signaling are unlikely to account
for the observed hypersensitive phenotype of Ripk2−/− mice. Similarly, we found no
significant differences in activation of NF-κB (pIκBα) and MAPK (pERK) pathways in
IAV-infected Ripk2−/− bone marrow derived dendritic cells (BMDCs) (data not shown). We
therefore analyzed processes directly regulating IL-18 maturation rather than IL-18
transcript abundance. Unlike most cytokines, IL-1β and IL-18 are produced as propeptides
that require proteolytic maturation by the cysteine protease caspase-1 in order to be released
Lupfer et al. Page 4
Nat Immunol. Author manuscript; available in PMC 2013 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
in their biologically active forms31. Notably, both caspase-1 activation and release of mature
IL-18 and IL-1β were markedly increased in PR8 infected Ripk2−/− and Nod2−/− BMDCs
(Fig. 5a–b). Although we initially detected increased IL-18 levels in vivo, low amounts of
IL-1β likely confounded detection of differences in this cytokine in vivo (Supplementary
Fig. 3a). Next, we examined caspase-1 activation to other IAV infections. We observed that
the ×31 low pathogenicity virus also elicited higher caspase-1 activation in Ripk2−/−
BMDCs (Supplementary Fig. 3b). We also examined inflammasome activation during
infection with bacteria known to activate the RIPK2 signaling pathway. Infection with
Listeria failed to augment caspase-1 processing and IL-18 production in Ripk2−/− and
Nod2−/− BMDCs (Figs. 5c–d). This enhancement of inflammasome activation by IAV in
Ripk2−/− BMDCs was dependent on NLRP3, as the NLRP3 specific inhibitor glyburide32
significantly inhibited caspase-1 activation and IL-18 production (Fig. 5e–f). In the case of
Listeria infection, the AIM2 inflammasome plays a predominant role in inflammasome
activation33. In agreement, Aim2−/− BMDCs showed nearly complete impairment in
caspase-1 activation following Listeria infection (Fig. 5g). These data indicate that enhanced
NLRP3 inflammasome activation occurs in Ripk2−/− BMDCs during IAV infection, but not
Listeria infection, indicating that this pathway is not a global disregulation of inflammasome
activation, but specific to the NLRP3 inflammasome.
RIPK2 regulates the NLRP3 inflammasome through autophagy
To determine the mechanism by which RIPK2 dampens inflammasome activation, we first
assessed the effect of RIPK2 overexpression on caspase-1 maturation and IL-18 release in
transfected 293T cells. In agreement with published reports34, overexpressed RIPK2
interacted with caspase-1 but this interaction enhanced, rather than inhibited, caspase-1
processing and IL-18 release (data not shown) indicating that RIPK2 overexpression is not
capable of directly inhibiting inflammasome activation. Because Ripk2−/− BMDCs do not
display a global defect in inflammasome activation (see Fig. 5), this suggests that RIPK2
may modulate caspase-1 indirectly in our model. In this regard, autophagy was recently
described to negatively regulate inflammasome activation during bacterial
infections17, 35, 36. We therefore hypothesized that Ripk2−/− and Nod2−/− BMDCs might be
defective in autophagy induction in response to IAV infection. LC3 lipidation is an
important step in the formation of autophagosomes. Therefore, one method to examine
autophagic activity is to examine the level of LC3-II (lipidated form). In agreement with our
hypothesis, Ripk2−/− and Nod2−/− BMDCs had significantly lower amounts of LC3-II
protein than WT BMDCs infected with either PR8 or ×31 (Fig. 6a and Supplementary Fig.
4a). It should be noted that turnover of autophagosomes, which results from their fusion
with lysosomes, was not affected by IAV infection in WT or Ripk2−/− BMDCs as treatment
with the lysosomal fusion inhibitor chloroquine resulted in the expected accumulation of
LC3-II+ puncta by immunofluorescence and LC3-II conversion by Western blot (Figure 6b–
c and Supplementary Fig. 4b). Finally, we counted autophagosomes by electron microscopy
and determined that Ripk2−/− BMDCs had significantly fewer autophagosomes following
IAV infection than WT BMDCs (Supplementary Fig. 4c–e). To establish the potential role
of differential autophagy induction in caspase-1 activation, we compared WT, Ripk2−/− and
LysM-Cre+Atg7flox/flox bone marrow-derived macrophages (BMDMs) which lack a critical
component of the autophagy machinery in myeloid cells. Both Ripk2−/−and Atg7−/−
BMDMs responded to IAV infection with enhanced caspase-1 activation relative to WT
macrophages (Supplementary Fig. 4f). To further confirm the role of autophagy in Ripk2−/−
cells, we treated Ripk2−/− BMDCs with rapamycin to force the induction of autophagy.
Following rapamycin treatment, IL-18 production and caspase-1 activation in Ripk2−/−
BMDCs was diminished to WT levels (Fig. 6d–e). We next verified the role of autophagy in
vivo and found that LC3-II protein was reduced in the lungs of IAV infected Ripk2−/− mice
as well (Fig. 6f). We also examined the effects of inducing autophagy in vivo with
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rapamycin treatment in IAV-infected Ripk2−/− mice and observed that rapamycin treatment
dampened neutrophil recruitment and inflammatory cytokine production in Ripk2−/−mice
(Fig. 6g–h). Together, these results demonstrate that RIPK2 negatively regulates
inflammasome activation, inflammatory cytokine production and neutrophil recruitment by
inducing autophagy in IAV-infected cells and mice.
Viral RNA genomes activate autophagy through NOD2-RIPK2
To examine the mechanism by which NOD2 and RIPK2 induce mitophagy, we expressed
RIPK2 and NOD2 in the presence or absence of IAV infection and determined that infection
induces an interaction between RIPK2 and NOD2 (Supplementary Fig. 5a). Next, we
determined the viral ligand that triggers NOD2-RIPK2 signaling. The cytosolic delivery of
viral RNA analogues (poly I:C + lyovec transfection) was capable of inducing LC3-II
conversion in a RIPK2- and NOD2- dependent manner (Supplementary Fig. 5b). However,
extracellular delivery of naked poly I:C induced LC3-II conversion independently of the
RIPK2 pathway (Supplementary Fig. 5c). We also transfected BMDCs with purified viral
RNA (vRNA) genomes and determined that IAV vRNA induces autophagy in a RIPK2
dependent manner (Supplementary Fig. 5d). Finally, transfection of IAV vRNA followed by
ATP treatment resulted in enhanced IL-18 production in both Ripk2−/− and Nod2−/−
BMDCs (Supplementary Fig. 5e). These data indicate that cytosolic viral genomes activate
the cytosolic NOD2-RIPK2 signaling pathway to trigger autophagy.
NOD2-RIPK2 mediated mitophagy regulates the inflammasome
In addition to preserving cellular energy stores, autophagy is linked to the removal of
damaged mitochondria. Notably, mitochondrial damage and the subsequent release of
reactive oxygen species (ROS) is linked to activation of the NLRP3 inflammasome34,37. We
thus hypothesized that defective mitophagy induction in IAV-infected RIPK2-deficient cells
triggered increased inflammasome activation due to the accumulation of damaged
mitochondria. To investigate this possibility, we examined mitochondrial superoxide (SOX)
production following IAV infection. IAV infection increased mitochondrial SOX production
in Ripk2−/− and Nod2−/− BMDCs to a markedly higher extent than in WT BMDCs (Fig. 7a
and Supplementary Fig. 6a–b). To further confirm that mitochondrial damage was
responsible for our observed phenotype we also examined mitochondrial SOX during
Listeria infection. Although Listeria infection generated a more robust production of SOX
compared to IAV, there was no difference between WT and Ripk2−/− cells (Fig. 7b and
Supplementary Fig. 6c). We also counted damaged mitochondria (disrupted cristae) by
electron microscopy and determined that IAV infected Ripk2−/− BMDC have a higher ratio
of damaged to healthy mitochondria than WT controls (Supplementary Fig. 6d). We further
confirmed the role of mitophagy in our model by staining BMDCs infected with IAV or
Listeria with MitoTracker Green and examined the fluorescence intensity by flow
cytometry. Cells with higher geometric mean fluorescence intensity (MFI) indicate an
accumulation of mitochondria. Although Ripk2−/− cells tended to have more mitochondria
even before infection, we observed that IAV infected Ripk2−/− BMDC but not WT had an
increase in mitochondria, and furthermore, this increase was not seen with Listeria infected
Ripk2−/− cells (Fig. 7c and Supplementary Fig. 7a–c). We also confirmed these findings by
isolating DNA from BMDCs and comparing the ratio of nuclear DNA to mitochondrial
DNA. Using this approach, we also determined that there are more mitochondria in IAV
infected Ripk2−/− BMDCs compared to WT BMDCs (Supplementary Fig. 7d). As
mitophagy appears to be defective in Ripk2−/− cells, resulting in greater production of
mitochondrial SOX, we treated Ripk2−/− BMDCs with N-acetyl cysteine (NAC), a general
ROS inhibitor, and found significantly reduced IL-18 levels and caspase-1 activation
relative to control-treated Ripk2−/− BMDCs that were infected with IAV (Fig. 7d–e). Similar
results were obtained with the specific mitochondrial SOX inhibitor mitoTEMPO (Fig. 7f).
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To confirm the specificity of these results, we also treated Ripk2−/−Listeria-infected BMDCs
with NAC. In agreement with the role for the AIM2 inflammasome in Listeria infection, we
observed little or no effect of NAC treatment during Listeria infection (Supplementary Fig.
7e). Finally, we verified directly that mitophagy was reduced during IAV infection in
Ripk2−/− BMDCs by staining for LC3-II and mitochondria. The ratio of LC3-II puncta
colocalized with mitochondria by confocal microscopy was significantly reduced in
Ripk2−/− compared to WT BMDCs (Fig. 7g). These results indicate that the induction of
mitophagy during IAV infection, which is regulated by NOD2 and RIPK2, is essential for
the clearance of damaged mitochondria. In the absence of RIPK2 or NOD2, elevated
mitochondrial SOX production enhances NLRP3 inflammasome activation.
RIPK2 regulates mitophagy through its kinase activity
It was previously reported that RIPK2 regulates autophagy through the autophagy protein
ATG16L122, 23. However, another group found no interaction between RIPK2 and
ATG16L137. To examine how RIPK2 regulates mitophagy during viral infection, we first
examined the possibility that RIPK2 might interact with ATG16L1. We expressed RIPK2
and the autophagy related protein ATG16L1 in the presence or absence of NOD2 and IAV
infection. IAV infection was required for association of RIPK2, NOD2 and ATG16L1
(Supplementary Fig. 8a). However, we were unable to coimmunoprecipitate endogenous
RIPK2 and ATG16L1 or detect any significant colocalization by immunofluorescence
confocal microscopy in BMDCs during IAV infection (data not shown). Although the
overexpression data above suggests the interaction with ATG16L1 may play an important
role during IAV infection, this remains to be verified under endogenous conditions.
Furthermore, an interaction between RIPK2 and ATG16L1 still does not address the
upstream signaling which initiates mitophagy during infection. To begin to address the exact
mechanism by which mitophagy is regulated by RIPK2 in our model, we examined the role
of RIPK2's kinase activity during mitophagy induction. Treatment of WT BMDCs with the
p38 and RIPK2 inhibitor SB203580 resulted in reduced LC3-II conversion and increased
caspase-1 activation as well as increased IL-18 production (Fig. 8a–b). We confirmed that
this effect was due to RIPK2 inhibition by examining autophagy in p38Flox/Flox BMDCs.
p38 deficiency did not impact LC3-II conversion during IAV infection, indicating the effect
of SB203580 to be mediated by RIPK2 inhibition (Supplementary Fig. 8b). Next, we
examined autophagy proteins known to be activated by phosphorylation and discovered that
phosphorylation of ULK1 at Ser555 was reduced in Ripk2−/− BMDCs during IAV infection
although upregulation of total ULK1 was not affected (Fig. 8c). Phosphorylation at Ser555
of ULK1 is known to be important for its activation and ULK1 is known to play an
important role in mitophagy, especially during hematopoietic development38. We therefore
examined Ulk1−/− BMDCs and found that they also have increased caspase-1 activation
following IAV infection and this increased caspase-1 activation was suppressed by NAC
treatment (Fig. 8d). Furthermore, Ulk1−/− BMDCs have more mitochondrial damage and
increased mitochondrial mass compared to WT BMDCs (Fig. 8e–f and Supplementary Fig.
8c). Collectively, these data demonstrate that NOD2 and RIPK2 interact with each other in
response to IAV vRNA genomes and regulate mitophagy in a RIPK2 kinase and ULK1
dependent manner. Mitophagy is then responsible for removing damaged mitochondria and
preventing excessive NLRP3 activation and IL-18 production (Fig. 8g).
Discussion
Although the in vivo relevance of RIPK2-mediated signalling for immunity against bacterial
pathogens has been clearly demonstrated for pathogens like Helicobacter pylori and Listeria
monocytogenes39, 40, the role of RIPK2 in the immune response to viral infections in vivo
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has not been reported. In addition, the involvement of RIPK2 in signaling pathways other
than the regulation of NF-κB and MAP kinase has not been explored in detail.
The present analysis demonstrates that RIPK2 is critical for protection against IAV-induced
immunopathology during IAV infection. Moreover, our results demonstrate that RIPK2
functions by negatively regulating IL-18 and IFN-γ production in stromal and immune cells
of the pulmonary tract. In addition, we identify NOD2 as the NLR acting upstream of
RIPK2 in mediating protection against IAV-induced morbidity and mortality. These results
thus implicate NOD2 as a key partner in additional immune signaling pathways during viral
infection, beyond those previously discovered for type I IFNs25, 26.
Although we observed elevated IL-1β in vitro by infecting BMDCs with IAV, the amount of
IL-1β present in vivo was on the order of 5–10 times lower than that of IL-18. These low
amounts of IL-1β in vivo likely obscured our ability to detect differences in this cytokine
initially. We expect that IL-1β may also play some role in our model in vivo; however, the
importance of RIPK2-mediated dampening of IL-18 was illustrated by the marked effect of
IL-18 neutralizing antibodies in reducing the morbidity and mortality in Ripk2-deficient
mice infected with IAV and was further confirmed in Ripk2−/−Il18−/− mice. This
demonstrates that excessive IL-18 production in Ripk2−/−mice drives the majority of the
immunopathology.
Immunopathology is a key factor in acute fatal IAV pneumonia in humans and in animal
models infected with highly virulent IAV strains41, 42. The present finding that IL-18
mediates hyper-inflammatory responses in Ripk2−/− mice thus opens new possibilities for
the treatment of severe IAV infections. In other disease models, elevated IL-18 has been
shown to promote neutrophil infiltration, and to mediate the production of IFN-γ and
chemokines (LPS toxemia and ischemic reperfusion, respectively). Reducing IL-18 in these
experimental systems limits the extent of tissue damage and promotes survival43, 44.
Blocking IL-18 may limit the extent of lung immunopathology in situations where IAV
infection leads to extreme respiratory distress.
At the molecular level, our data show that RIPK2 dampens harmful IL-18-driven
inflammatory responses against IAV by preventing excessive activation of caspase-1
through a mitophagy-mediated suppression mechanism, rather than via a direct interaction
with caspase-1. Multiple inflammasomes that activate caspase-1 in a pathogen-dependent
manner have been identified. However, our previous studies identified a critical role for the
NLRP3 inflammasome in regulating IL-1β and IL-18 production to IAV infection both in
vivo and in vitro12, 13. We here extended these findings by showing that RIPK2-mediated
inhibition of inflammasome activation proceeds through the removal of damaged
mitochondria and reduction of mitochondrial SOX production, a known activator of the
NLRP3 inflammasome35, 45. The role for the NLRP3 inflammasome in our model was also
verified by treatment with the NLRP3 specific inhibitor glyburide.
Many reports differ on the mechanism by which RIPK2 regulates the induction of autophagy
or xenophagy in response to bacterial infection20, 22, 23, 37. In fact there are differing reports
on the role of RIPK2 and ATG16L1 during bacterial infection22, 23, 37. Although we
observed an interaction between these two proteins when overexpressed, we were unable to
verify this interaction in BMDCs during IAV infection, despite the use of multiple methods
and conditions. We therefore sought out other potential mechanisms by which RIPK2 could
regulate autophagy. We discovered that Ripk2−/− BMDCs had increased mitochondrial
damage and more mitochondrial mass, suggesting that mitophagy was defective. In our
search to identify the mechanisms involved in RIPK2 mediated mitophagy, we examined the
mitophagy protein Parkin through the use of Parkin deficient mice (Park2−/−). However, we
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were unable to observe any role for Parkin in our model (data not shown). In the end, we
discovered that activation of ULK1 by phosphorylation at Ser555 was reduced in Ripk2−/−
BMDCs. The importance of ULK1 was also verified in our model as Ulk1−/− BMDCs
phenocopy Ripk2−/− BMDCs with regard to mitochondrial damage and inflammasome
activation. Our findings highlight a signaling pathway in which NOD2 and RIPK2 respond
to viral infection by promoting ULK1 phosphorylation and inducing mitophagic responses
which dampen inflammasome activation and IL-18 production. Although it is clear that
Ripk2 deficiency results in reduced ULK1 phosphorylation, it is not clear whether RIPK2
directly phosphorylates ULK1 or if there are other intermediates which are regulated by
RIPK2 which subsequently activate ULK1.
It should be noted that autophagy was recently shown to directly clear inflammasomes from
activated cells, thus modulating inflammation17. However, we were unable to observe any
role for autophagy in our system during Listeria infection dependent upon the AIM2
inflammasome, suggesting that global inflammasome degradation by macroautophagy is
likely not important in our model. Furthermore, virus replication was not affected in our
model, suggesting that xenophagy also does not play a significant role. Therefore, our data
are the first to demonstrate that NOD2-RIPK2 signaling can regulate mitophagy specifically
during viral infection and to demonstrate the physiological relevance of this pathway in
controlling pulmonary inflammation in vivo. It should also be noted that Rikp2−/− cells had
slightly higher basal levels of mitochondrial mass and damaged mitochondria. These data
may indicate a role for Ripk2 in the steady state regulation of mitophagy. In the future it will
be of interest to examine whether this can exacerbate other non-infectious diseases where
mitochondrial damage or metabolic stresses are known to be factors. In all, our findings
demonstrate that NOD2-RIPK2 signaling is involved in the recognition of a wider variety of
pathogens than previously thought, and we determined that RIPK2 can regulate ULK1
mediated mitophagy. Finally, our results provide a unifying principle by linking NOD2-
RIPK2 signaling, autophagy or mitophagy, and inflammasome-IL-18 production together,
suggesting that this pathway is a critical regulatory mechanism for preventing overt
inflammation under certain disease conditions.
Materials and Methods
Virus, bacteria and ligands
The influenza A/Puerto Rico/8/34 H1N1 virus (PR8) was generated by an eight-plasmid
reverse genetics system46. X31 virus was prepared similarly. Stocks were propagated no
more than twice by allantoic inoculation of 10-day-old embryonated hen's eggs with seed
virus diluted 1:104. Listeria monocytogenes was grown in brain heart infusion medium at 37
°C overnight and then subcultured to mid-log phase for infections. Poly I:C and Poly I:C
lyovec were obtained from Invivogen and used at the indicated concentrations. IAV
genomes, or cellular mRNA controls, were purified from viral stocks or BMDCs using
Trizol LS and transfected using Lipofectamine 2000 according to manufactures instructions.
Measuring virus titers
Near confluent 9.6 cm2 monolayers of Madin-Darby Canine Kidney (MDCK) cells were
infected with 1 mL aliquots of 6×10-fold dilutions of lung homogenate, washed and
overlayed with 3 ml minimum essential medium (MEM) containing 1 mg/ml L-1-
tosylamido-2-phenylethyl chloromethyl ketone-treated trypsin (Sigma Aldrich) and 1.0%
Sea Plaque agarose (Lonza). After 3 days, plaques were visualized with crystal violet.
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Mice
All mice were maintained at SJCRH and were fully on the C57BL/6J (B6) background.
Nod2−/−, LysM-Cre+ Atg7flox/flox GFP-LC3+, p38flox/flox (Mapk14flox/flox Rosa26-Cre-
ERT2), Ulk1−/− and Ripk2−/− 24, 32, 40, 47–49 mice have been reported previously and
Ripk2−/− × IL-18−/− double deficient mice were generated by backcrossing. All mice were
housed in a specific pathogen free (SPF) facility and experiments were conducted under
protocols approved by the St. Jude Children's Research Hospital Committee on Use and
Care of Animals.
Virus infection and sampling
Mice were anaesthetized with Avertin (2,2,2-tribromoethanol) and infected i.n. with the
indicated dose of the PR8 virus in 30μL of endotoxin-free PBS. In the case of IL-18
neutralization, mice were injected as indicated with 200μL of rabbit antiserum against
mouse IL-18 (C. A. Dinarello). For in vivo autophagy induction, mice were injected with
600μg/kg of rapamycin on D0, 1 and 2 and samples were collected 6h after the final
injection. Mice were either weighed and monitored for severe illness daily for a period of
14–16d, or taken at various intervals for sampling the whole lung. The right lungs were
processed by mincing and passing through a 70μm cell strainer using a total of 4ml HBSS.
Following light centrifugation, total cell numbers per lung or lymph node were determined
and stained for flow cytometry. In addition, HBSS supernatant was used for virus titration
and cytokine analysis. The left lungs were used for histopathological analysis or ground in
RIPA buffer + protease inhibitor + phosphatase inhibitor (Calbiochem) followed by boiling
in sodium dodecyl sulfate (SDS) sample buffer and examination by Western blot.
Flow cytometry
Aliquots of whole lung populations (as above) were stained for myeloid cells with anti-
CD11b, anti-MHC Class II, anti-GR1, anti-CD11c (Biolegend, M1/70, M5/114.15.2,
RB6-8C5, N418) MAbs, and annexin V after blocking the Fc receptor with anti-CD32/
CD16 MAb (from BD Pharmingen) at 4°C, and analyzed by flow cytometry.
(macrophages=CD11b+,CD11c−,GR1−,lo; granulocytes=CD11bhi,CD11c−,GR1hi;
DCs=CD11c+, MHC Class II+) Additionally, lymphocytes were stained with anti-CD19,
anti-TCRβ, anti-CD8, and anti-CD4 (Biolegend, 6D5, H57–597, 53–6.7, RM4–5). NK and
NKT cells were stained with anti-CD3 and anti-NK1.1 (Biolegend, 145-2C11, PK136). For
NK, NKT and CD8+ T cell activation experiments, anti-CD3 and anti-NK1.1 or anti-TCRβ,
anti-CD8 and anti-CD44 (Biolegend, IM7) markers were used. Intracellular IFN-γ
(Biolegned, XMG1.2) in CD8+ T cells was measured after stimulation of whole lung cells
for 5h at 37°C and 5% CO2 with a cocktail of IAV peptides (PB1, PB1-F2, NP, PA, M1) at
1ug/ml each with monensin. NK and NKT cells were similarly restimulated with 10ng/ml
IL-12. Cell numbers are 1/10 of the total number present in the right lung lobes or 1/3 of the
number present in the mediastinal lymph node
For staining mitochondria, BMDCs were uninfected as controls or infected for 6h with
Listeria or 18–24h with PR8 influenza and then stained for 30 min in fresh complete
RPMI1640 medium containing 5μM MitoSOX or 2μM MitoTracker Green. Cells were then
washed in HBSS, resuspended in FACS buffer and analyzed immediately by flow
cytometry.
Assaying for cytokines and chemokines
Mouse cytokines and chemokines in HBSS supernatants from whole lung homogenates were
measured using the Millipore 22-multiplex assay following the manufacturer's instructions.
In addition, lung samples and supernatants from BMDC cultured in vitro were assayed by
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ELISA for IL-18 (MBL International, Woburn, MA) and IL-1β or IFN-γ (eBiosciences). All
cytokines from lung homogenates were normalized to the total protein in the homogenate by
BCA protein assay (Pierce) and expressed as cytokine concentration per milligram total
protein (pg/mg t.p.)
Histopathological analysis, transmission electron microscopy and confocal microscopy
Formalin-preserved left lungs were embedded in paraffin and processed by standard
techniques. Longitudinal 5μm sections were stained with H&E and examined by an
experienced pathologist blinded to the experimental groups. For immunohistochemistry,
formalin-fixed paraffin-embedded tissues were cut into 4-μm sections and slides were
stained with Abs to identify IL-18 (MBL International, Woburn, MA, clone 39–3F) and
neutrophils (7/4 monoclonal antibody, Invitrogen).
For transmission electron microscopy, cells were fixed in a solution of 2.0%
paraformaldahyde + 2.5% glutaraldehyde in 0.1 m cacodylate buffer (pH 7.4). Cells were
then embedded and sectioned for transmission electron microscopy by the Cell and Tissue
Imaging Core Facility of St. Jude Children's Research Hospital.
For examination of LC3+ puncta numbers or colocalization with mitochondria by confocal
microscopy, BMDCs were infected with IAV at 10MOI and/or treated with 50μM
chloroquine (Calbiochem) 1h after infection. After 18h, cells were treated with 100nM
MitoTracker Orange CMTMRos for 30min. Cells were then fixed in 4% paraformaldehyde
in PBS+100mM HEPES buffer. Cells were permeablized with methanol at −20°C for 5 min,
washed 3× in PBS, and then blocked using 1× assay buffer (eBiosciences) + 0.1%Triton
×100 for 1h. Cells were stained overnight at 4°C with a 1:500 dilution of anti-LC3B
antibody (Novus Biologicals, NB600–1384) in blocking buffer. Cells were washed 3× and
then stained with Alexa488 donkey anti-rabbit secondary (Invitrogen, A-21206) for 2h in
blocking buffer. Cells were washed an additional 3× and then mounted using Prolong
GOLD with DAPI (Invitrogen) and examined on a Nikon C1Si laser scanning confocal
microscope. Data analysis was performed using ImageJ.
Generation of bone marrow chimeras
WT (CD45.1) and Ripk2−/− (CD45.2) mice, were lethally irradiated with a split dose of
1200 rads (800,400), then injected with 5 × 106 bone marrow (BM) cells from the indicated
donors. Mice were allowed to recover for 6 weeks to ensure successful engraftment. The
extent of BM reconstitution was verified by staining lymphocytes with anti-CD45.1 APC
and anti-CD45.2 FITC (Biolegend, A20, 104) for congenic markers, and was always > 90%.
Cell signaling, caspase-1 activation and IL-18 production in vitro
WT, Nod2−/− and Ripk2−/− bone marrow derived dendritic cells (BMDC) were
differentiated in complete RPMI containing 10% heat-inactivated FBS and supplemented
with 20ng/ml murine GM-CSF at 37°C in a humidified atmosphere containing 5% CO2 for 7
days. Cells were mock infected, or infected with 10 MOI PR8 or 10 MOI ×31 for 24h or 10
MOI Listeria monocytogenes for 4–6h in antibiotic free medium. For N-acetyl cysteine
(NAC, Sigma-Aldrich) or mitoTEMPO (Enzo Life Sciences) treatment, BMDCs were
infected with 10 MOI PR8 for 1h and then fresh RPMI 1640 with 10% FBS containing the
indicated concentrations of inhibitors were added. Other inhibitors, including glyburide
(Sigma-Aldrich), rapamycin or SB203580 (Calbiochem) were also added 1h after infection.
18–24h later, supernatants were collected for ELISA and cells were lysed with RIPA buffer
+ protease inhibitor + phosphatase inhibitor (Calbiochem), followed by boiling in sodium
dodecyl sulfate (SDS) sample buffer and examination by Western blot. Anti-caspase-1
(Adipogen, AG-20B-0042), anti-ULK1 (Sigma-Aldrich, A7481), anti-LC3 (Novus
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Biologicals, NB600–1384), and anti-pUlk1 Ser555 (Cell Signaling Technologies, D1H4),
were used for Western blot detection and equal loading was verified by blotting with anti-
GAPDH or anti-β-Tubulin (Cell signaling Technologies, D16H11, 9F3). HRP-labeled anti-
rabbit antibodies were obtained from Jackson Immuno Research.
Overexpression and Coimmunoprecipitation
293T cells were transfected using Lipofectamine 2000 (Invitrogen) or Xfect (Clontech)
according to the manufacturer's protocol and harvested 24h after transfection for
examination by coimmunoprecipitation (CoIP) and/or by Western blot. For CoIP, 3–4 10cm
wells each were transfected with pCMV6-Kan/Neo-RIPK2 (Origene), pBK-flag-NOD2, or
pCMV-3xMyc-ATG16L1 and cells were lysed after 24h in DPBS with 1% NP40 + protease
inhibitors + phosphatase inhibitors (Calbiochem). In some experiments, 293T cells were also
infected with 10 MOI influenza A/PR/8/34 H1N1 1h prior to transfection. CoIP was
performed overnight at 4°C with protein A/G PLUS agarose beads (SantaCruz) and rabbit
anti-RIPK2 (SantaCruz, H300), mouse anti-Flag (Sigma, M2), and rabbit anti-Myc
(SantaCruz, A14) antibodies. Western blot was then performed with rabbit anti-RIPK2,
rabbit anti-Flag (Sigma, F7425), rabbit anti-Myc and Exactacruz HRP anti-rabbit secondary
(SantaCruz, SC-45043).
Statistical analysis
Data are represented as mean ± SEM. Statistical significance was determined by a Student t-
test, one-way ANOVA for multiple comparisons, and Kaplan-Meier Survival Plot and
LogRank Test for survival data. Data for LC3+ puncta was not normally distributed and data
were analyzed by the Mann Whitney test. P values ≤0.05 were considered statistically
significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. RIPK2 deficiency leads to hyper-inflammation
(a) Mice were infected intra-nasally (i.n.) with 750 PFU of the PR8 virus and examined
daily for survival and clinical features of disease. (b) H&E-stained lung sections from mice
infected with PR8 virus on day 2. Cellular infiltrates and necrotic debris occluding the
airways are indicated with arrows. (c) H&E-stained lung sections were prepared on day 2
post-infection and scored for disease severity and necrosis. (d) The extent of cell death on
day 7 was estimated visually on H&E-stained lung sections (necrosis score), and by flow
cytometry for annexin V-stained lung cell populations. (e) Immunohistochemistry (IHC)
staining of neutrophils occluding the airways of PR8 infected Ripk2−/− mice. (f-g) Flow
cytometric analysis of neutrophil, DC and macrophage cell numbers on days 2 and 7. (h)
Pulmonary viral titers on days 2 and 7 after infection in Ripk2−/− and WT mice. a,f,g,h: Data
are cumulative from 3 independent experiments (g-h: n=10–12). b-e: Data are representative
of 2-3 independent experiments n=3–7 per group/experiment (mean +/−SEM, *p<0.05,
**p<0.01, ***p<0.001).
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Figure 2. RIPK2 modulates cytokine and chemokine production
Supernatants of whole lung homogenates taken on d2 and d7 after infection with the PR8
virus were analyzed for IL-6 and TNF (a), IL-18 and IFN-γ (b), and a set of chemokines (c).
Data were normalized for total protein from lung homogenates (pg/mg total protein (t.p.)).
Data are cumulative from 3 independent experiments, n=10–12 mice. (mean +/−SEM,
*p<0.05, **p<0.01).
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Figure 3. IL-18 mediates hyper-inflammation in Ripk2−/− mice
Ripk2−/− mice were injected i.p. with anti-IL-18 neutralizing antiserum (αIL-18Ab) 3h prior
to infection with the PR8 virus. Mice were examined on d2 for IL-18, IFN-γ, and CCL2
levels in whole lung homogenates (a), and for neutrophil numbers by IHC (b) and by flow
cytometry (c). (d) Analysis of survival of infected Ripk2−/− mice that were treated with
IL-18 neutralizing antibodies. (e) IL-18 was deleted from Ripk2−/− mice
(Ripk2−/−Il18−/−mice) and neutrophilia examined on d2 following PR8 infection. (f)
Survival of Ripk2−/−Il18−/− mice compared to Ripk2−/− or WT mice. Data are representative
of 2 independent experiments, n=6–8 per group/experiment. (mean +/−SEM, *p<0.05,
**p<0.01, ***p<0.001). (t.p.=total protein)
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Figure 4. Both hematopoietic and lung epithelial cells contribute to hypercytokinemia
RIPK2 bone marrow chimeras were analyzed at d2 after PR8 infection for contribution to
elevated IL-18 production by using (a) IL-18 IHC and (b) IL-18 ELISA of whole lung
homogenates. (c) Flow cytometric analysis of NK cell counts in Ripk2−/− and WT mice. (d)
Analysis of WT and Ripk2−/− NK cells for IFN-γ production on a per cell basis. (e)
Accumulation of T and B cells in lungs. (f) Analysis of CD8+ T cells for IFN-γ and CD44
expression in WT and Ripk2−/− mice. Data are representative of 2–3 independent
experiments, n=6–8 per group/experiment. (mean +/−SEM, *p<0.05, **p<0.01). For (a),
blue arrows denote IL-18+ macrophages, and red arrows denote IL-18+ bronchial
epithelium.
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Figure 5. Elevated IL-18 in Ripk2−/− cells is NLRP3 inflammasome dependent
(a) Increased activation of caspase-1 (casp-1) in Ripk2−/− and Nod2−/− BMDCs following
PR8 infection was analyzed by probing for active casp-1 p20 in immunoblots compared to
GAPDH loading controls. (b) IL-18 release in PR8-infected Ripk2−/− and Nod2−/− BMDCs.
(c, d) BMDCs infected with 10 MOI Listeria monocytogenes for 4h were analyzed for
casp-1 activation by immunoblot and IL-18 production. (e, f) IL-18 and casp-1 activation in
Ripk2−/− BMDCs treated with the NLRP3 inflammasome specific inhibitor glyburide during
PR8 infection. (g) Immunoblot for casp-1 p20 during Listeria infection of WT and Aim2−/−
BMDCs. Data are representative of 3–6 independent experiments with n=3 per experiment.
(mean +/−SEM; *p<0.01, **p<0.001).
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Figure 6. RIPK2 modulates inflammasome activation through autophagy
(a) Ripk2−/− and Nod2−/− BMDCs were analyzed by LC3-II imunoblotting as a marker for
autophagy after 18h PR8 infection. (b, c) LC3-II+ puncta were counted in at least 100 cells
from 5 random fields from confocal images of BMDCs following PR8 infection and/or
chloroquine treatment. (d, e) Immunoblots of LC3-II and casp-1 and IL-18 production were
determined in WT and Ripk2−/−BMDCs following treatment with rapamycin (Rap). (f)
LC3-II levels in the lungs of PR8 infected WT and Ripk2−/− mice. (g, h) Lung neutrophil
infiltration, IL-18 and IFN-γ levels in IAV infected Ripk2−/− mice treated with rapamycin.
(a–e) Data are representative of 2–6 independent experiments with n=2–3 per experiment.
(f–h) Data are representative of 2 independent experiments for a total n=10–14 (mean +/
−SEM; *p<0.05, **p<0.01, ***p<0.001).
Lupfer et al. Page 20
Nat Immunol. Author manuscript; available in PMC 2013 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 7. RIPK2 specifically regulates mitophagy and accumulation of damaged mitochondria to
modulate inflammasome activation
(a, b) Staining of BMDCs with the mitochondrial superoxide (SOX) specific stain MitoSOX
during IAV or Listeria infection. (c) Staining of WT and Ripk2−/− BMDCs with the general
mitochondrial stain MitoTracker Green during IAV infection. (d, e) Analysis of IL-18
production and casp-1 activation in IAV-infected BMDCs that were pre-treated with the
ROS inhibitor N-acetyl cysteine (NAC). (f) Analysis of casp-1 p20 in cell lysates of IAV-
infected BMDCs pre-treated with the mitochondrial SOX inhibitor mitoTEMPO. (g)
Confocal microscopy was used to analyze BMDCs stained for mitochondria (red) and LC3-
II (green) for colocalization as an indicator of mitophagy. (a–f) Data are representative of 3–
9 independent experiments with n=2–3 per experiment. (g) Data are representative of 2
independent experiments (mean +/−SEM; *p<0.01).
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Figure 8. RIPK2 regulates activation of the critical autophagy protein ULK1 in response to IAV
infection
(a, b) Casp-1 p20 and LC3-II immunoblots and IL-18 levels in PR8-infected WT BMDCs
treated with the p38 and RIPK2 kinase inhibitor SB203580. (c) Immunoblots of
phosphorylation of ULK1 at Ser555 in WT and Ripk2−/− BMDCs following PR8 infection.
(d) Casp-1 activation in untreated or NAC treated WT and Ulk1−/− BMDCs following PR8
infection. (e) MitoSOX staining by flow cytometry in PR8-infected Ulk1−/− BMDCs. (f)
MitoTracker Green staining of PR8-infected Ulk1−/− BMDCs. (g) Schematic diagram of the
NOD2/RIPK2 dependent mechanism for mitophagy and subsequent NLRP3 inflammasome
regulation. (a–f) Data are representative of 2–3 independent experiments with total n=4–6.
(mean +/−SEM; *p<0.05).
Lupfer et al. Page 22
Nat Immunol. Author manuscript; available in PMC 2013 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
